ADME studies provide valuable insight into a drug’s profile in vivo, as well as a preview of what may be observed clinically. We offer GLP-compliant ADME through validated test systems to support international regulatory requirements. Experienced staff and dedicated team are involved in all aspects of study conduct to ensure all essential information is properly analyzed.

We have established experience conducting pharmacokinetic (PK) studies including drug half-life, biodistribution, bioavailability and safety evaluation. We offer bioanalytical methods of development and validation to identify and quantify test articles, metabolites and degradation products in blood, urine and other biological fluids or tissues.